Home > Healthcare > Pharmaceuticals > Finished Drug Form > Wound Care Market

Wound Care Market Share

Report ID: GMI7515
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Wound Care Market Share

The wound care industry is consolidated, with key players including, Smith & Nephew, B. Braun Melsungen AG, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in September 2021, Omeza announced that the U.S. FDA had approved its Omeza collagen matrix. This matrix is made of hydrolyzed fish collagen and is used to treat chronic wounds such as diabetic ulcers, surgical wounds, draining wounds, and partial and full-thickness wounds. Thus, rising product approvals is projected to augment industry expansion.

Some of the eminent market participants operating in the wound care industry include:

Smith & Nephew
Mölnlycke Health Care AB
ConvaTec Group PLC
Ethicon (Johnson & Johnson)
Baxter International
URGO Medical
Coloplast Corp.
Medtronic
3M Company
Derma Sciences Inc. (Integra LifeSciences)
Medline Industries
Advancis Medical
B. Braun Melsungen AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global wound care industry was valued at USD 21.2 billion in 2022 and is estimated to reach USD 37.3 billion by 2032, owing to the increasing incidence of burn injuries, and prevalence of diabetes.

The advanced wound dressing segment of wound care industry garnered USD 6 billion in 2022 and will continue to see demand attributed to its versatility and effectiveness in wound care.

U.S. wound care market accounted for USD 8 billion in 2022 and is predicted to witness substantial growth over 2023-2032, favored by the increasing government initiatives towards diabetes care.

Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp., Medtronic, 3M Company, and Derma Sciences Inc. (Integra LifeSciences) among others.